Articles

Article

Oncology Decentralized Trials call for special consideration: Encapsia

Oncology Decentralized Trials call for special consideration: Encapsia

Encapsia spoke to Outsourcing-Pharma about some of the challenges unique to cancer-focused DCTs, and technologies that can help overcome some of these special obstacles.

Read more on Outsourcing Pharma

Article

The Source and the Story – How Digital Transformation Truly Centers Patients

The Source and the Story – How Digital Transformation Truly Centers Patients

This article is taken from International Clinical Trials February 2022, pages 8-10 © Samedan Ltd

Article

Predictions and perspectives on the future of DCTs

Predictions and perspectives on the future of DCTs

“The message was clear from industry leaders this year whether on social media or conferences: today’s clinical trials need decentralised solutions”, says Temitope Keyes, Executive Director Business Development at encapsia, commenting on the decentralised clinical trial (DCT) event horizon.

Read more on Drug Discovery World

Article

Updates Ready: Reboot Necessary

Updates Ready: Reboot Necessary

Clinical trials are now more complex than ever, and technology has not kept pace. Though a shift to digital decentralization has begun, all too often the solutions are just stitched onto already underperforming legacy systems.

Read more on The Medicine Maker

Article

Getting the right tech tools vital to decentralized trial transition

Getting the right tech tools vital to decentralized trial transition

Mark Tomlinson, Senior Director of Technology Operations at encapsia, explains how taking stock of existing tech and adding the right new tools can help when switching to virtual clinical studies.

Read more on Outsourcing Pharma

Article

Enabling Decentralized Clinical Trials through Digital Transformation

Enabling Decentralized Clinical Trials through Digital Transformation

To properly support and enable DCTs, we must undergo a digital transformation; we must eliminate the pain involved in aggregating and integrating data from multiple sources, reduce the lag between data capture and data analysis, and improve the ability of study teams to gain deeper insights and operationalize the data.

Read more on Contract Pharma

Article

Personalized Medicine: A Work in Progress

Personalized Medicine: A Work in Progress

Advances in big-data analytics are increasingly being employed to extract targeted information with the potential to drive life-sciences research and clinical practice closer to the goal of personalized and precision medicine.

Read more on PharmaVoice

Article

Clinical Trials in 3D – DCT, Data Science and Digital Transformation

Clinical Trials in 3D – DCT, Data Science and Digital Transformation

This article is taken from International Clinical Trials May 2021, pages 50-52. © Samedan Ltd.

Latest articles

Why decentralizing clinical trials helps with patient recruitment and retention

Patient recruitment and retention can be a challenge at various points in the clinical development process. Research suggests these challenges can lead to delays of between 1 to 6 months for most clinical trials. More, 11% of clinical research sites…

Read article

What are the four phases of clinical trials?

Clinical trials studying and evaluating new drugs evolve through a number of different stages known as 'phases". Early phase trials examine the safety and dosing of the candidate drugs, while later phase trials are concerned more with safety, tolerability and…

Read article

How to secure quality trial data that delivers a return on investment

The clinical trial landscape has seen unprecedented advances in automated data collection. Cutting-edge technology enables the interrogation and aggregation of vast quantities of data, which brings with it significant challenges in analysis and interpretation. Drug discovery and development is a…

Read article